Advanced in Superficial Thrombophlebitis

Sebastian M. Schellong

Dresden, SN, DE 
Advanced in Superficial Thrombophlebitis
Dresden, SN, DE 
OverviewLocationsClinical Research

Overview

Sebastian Schellong practices in Dresden, Germany. Mr. Schellong is rated as an Advanced expert by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Deep Vein Thrombosis, Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Pulmonary Embolism, and Angioplasty.

His clinical research consists of co-authoring 173 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Superficial Thrombophlebitis.

Gender
Male

Locations

Dresden, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D
A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D
Enrollment Status: Completed
Publish Date: April 17, 2025
Intervention Type: Device
IDOMENEO: Multimethodical and Multistage Registry-based Longitudinal Study Project to Collect Primary Registry Data and Health Insurance Claims Data of Patients Invasively Treated for Peripheral Artery Disease (PAD) in Germany
IDOMENEO: Multimethodical and Multistage Registry-based Longitudinal Study Project to Collect Primary Registry Data and Health Insurance Claims Data of Patients Invasively Treated for Peripheral Artery Disease (PAD) in Germany
Enrollment Status: Completed
Publish Date: December 22, 2022
Intervention Type: Procedure
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Enrollment Status: Terminated
Publish Date: December 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
Telemedical Interventional Management in Heart Failure II
Telemedical Interventional Management in Heart Failure II
Enrollment Status: Completed
Publish Date: August 03, 2018
Intervention Type: Other, Device
Study Phase: Phase 3
View 3 Less Clinical Trials

173 Total Publications

Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry.
Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry.
Journal: European journal of internal medicine
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schellong's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile